ATE455786T1 - 6-11 bicyclische ketolidderivate - Google Patents

6-11 bicyclische ketolidderivate

Info

Publication number
ATE455786T1
ATE455786T1 AT03733983T AT03733983T ATE455786T1 AT E455786 T1 ATE455786 T1 AT E455786T1 AT 03733983 T AT03733983 T AT 03733983T AT 03733983 T AT03733983 T AT 03733983T AT E455786 T1 ATE455786 T1 AT E455786T1
Authority
AT
Austria
Prior art keywords
present
compounds
subject
ketolide derivatives
invention further
Prior art date
Application number
AT03733983T
Other languages
English (en)
Inventor
Yat OR
Guoqiang Wang
Ly Phan
Deqiang Niu
Nha Huu Vo
Yao-Ling Qiu
Yanchun Wang
Marina Busuyek
Ying Hou
Yulin Peng
Heejin Kim
Tongzhu Liu
Jay Judson Farmer
Guoyou Xu
Original Assignee
Enanta Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharm Inc filed Critical Enanta Pharm Inc
Priority claimed from PCT/US2003/014669 external-priority patent/WO2003097659A1/en
Application granted granted Critical
Publication of ATE455786T1 publication Critical patent/ATE455786T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT03733983T 2002-05-13 2003-05-09 6-11 bicyclische ketolidderivate ATE455786T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14455802A 2002-05-13 2002-05-13
US10/429,485 US6878691B2 (en) 2002-05-13 2003-05-05 6-11 bicyclic ketolide derivatives
PCT/US2003/014669 WO2003097659A1 (en) 2002-05-13 2003-05-09 6-11 bicyclic ketolide derivatives

Publications (1)

Publication Number Publication Date
ATE455786T1 true ATE455786T1 (de) 2010-02-15

Family

ID=34134634

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03733983T ATE455786T1 (de) 2002-05-13 2003-05-09 6-11 bicyclische ketolidderivate

Country Status (11)

Country Link
US (1) US6878691B2 (de)
KR (1) KR100687956B1 (de)
CN (1) CN102127133B (de)
AT (1) ATE455786T1 (de)
CY (1) CY1109970T1 (de)
DE (1) DE60331056D1 (de)
DK (1) DK1506214T3 (de)
ES (1) ES2339647T3 (de)
HK (1) HK1074447A1 (de)
PT (1) PT1506214E (de)
TW (1) TWI327573B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
JP2005536465A (ja) * 2002-05-13 2005-12-02 エナンタ ファーマシューティカルズ インコーポレイテッド ６，１１二環式エリスロマイシン誘導体
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
EP1599491A1 (de) * 2003-03-05 2005-11-30 Rib-X Pharmaceuticals, Inc. Bifunktionelle heterozyklische verbindungen und verfahren zu deren herstellung
WO2005028493A1 (en) * 2003-09-12 2005-03-31 Chiron Corporation Antimicrobial derivatives
JP2007509980A (ja) * 2003-10-30 2007-04-19 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 二官能性マクロライド複素環式化合物およびそれらの化合物を調製および使用する方法
EP1699808A1 (de) * 2003-11-18 2006-09-13 Rib-X Pharmaceuticals, Inc. Bifunktionelle heterocyclische macrolidverbindung und verfahren zu deren herstellung und deren anwendung
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US8202843B2 (en) * 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US20060058247A1 (en) * 2004-09-16 2006-03-16 Yujiro Hata Methods and compositions for treating cystic fibrosis
US7538225B2 (en) * 2005-05-02 2009-05-26 Enanta Pharmaceuticals, Inc. Processes for the preparation of o-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
US20060252710A1 (en) * 2005-05-04 2006-11-09 Guoqiang Wang 6-11 Bridged oxime erythromycin derivatives
JP2008540432A (ja) * 2005-05-04 2008-11-20 エナンタ ファーマシューティカルズ インコーポレイテッド ６−１１橋かけオキシムエリスロマイシン誘導体
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
US7589067B2 (en) * 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
EP1960413A2 (de) * 2005-11-23 2008-08-27 Ranbaxy Laboratories Limited Makrolidderivate als antibakterielle mittel
US7563877B2 (en) * 2006-03-02 2009-07-21 Enanta Pharmaceuticals, Inc. Processes for the preparation of 0-(2-aminobenzo[d]oxazol-5-yl)methyl hydroxylamine for the synthesis of 6,11-bicyclic erythromycin derivative EDP-182
US20070231368A1 (en) * 2006-03-30 2007-10-04 Enanta Pharmaceuticals, Inc. Pharmaceutical formulations of 6-11 bicyclic macrolide derivative known as edp-182 and methods for preparation thereof
WO2007143507A2 (en) * 2006-06-05 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
WO2008014221A2 (en) * 2006-07-24 2008-01-31 Enanta Pharmaceuticals, Inc. Bridged carbamate macrolides
US20080039406A1 (en) * 2006-08-04 2008-02-14 Yao-Ling Qiu 3,6-bridged tylosin derivatives
US7622452B2 (en) * 2006-11-16 2009-11-24 Enanta Pharmaceuticals, Inc. C-9 alkenylidine bridged macrolides
US7524512B2 (en) * 2007-07-13 2009-04-28 Di Bartolomeo Joseph R Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US20090075915A1 (en) * 2007-09-17 2009-03-19 In Jong Kim 6,11-bicyclolides: bridged biaryl macrolide derivatives
WO2009064953A1 (en) * 2007-11-15 2009-05-22 Enanta Pharmaceuticals, Inc. Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
US8552162B2 (en) * 2008-05-09 2013-10-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
US7842813B2 (en) * 2008-05-09 2010-11-30 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine
KR101118597B1 (ko) * 2008-12-24 2012-02-27 한국전자통신연구원 모바일용 컴퓨터 그래픽 랜더링 방법 및 시스템
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
AU2012355690B2 (en) * 2011-12-19 2017-02-02 Biosynthetic Technologies, Llc Processes for preparing estolide base oils and oligomeric compounds that include cross metathesis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960000434B1 (ko) 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
US4921836A (en) 1989-05-17 1990-05-01 Burroughs Wellcome Co. Substituted glutamic acids
IL99995A (en) 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
WO1992009614A1 (fr) 1990-11-28 1992-06-11 Taisho Pharmaceutical Co., Ltd. Derive de 6-o-methylerythromycine a
US5202434A (en) 1991-04-05 1993-04-13 Merck & Co., Inc. 8a-aza-8a-homoerythromycin lactams
US5556839A (en) 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
KR0166996B1 (ko) 1992-04-22 1999-01-15 우에하라 아키라 5-o-데소사미닐에리쓰로노라이드a 유도체
US5527780A (en) 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
US5441939A (en) 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
FR2738571B1 (fr) 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US6124269A (en) 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
US6046171A (en) 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
US6458771B1 (en) 1999-04-16 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials

Also Published As

Publication number Publication date
CN102127133B (zh) 2015-04-15
TW200400969A (en) 2004-01-16
CN102127133A (zh) 2011-07-20
TWI327573B (en) 2010-07-21
PT1506214E (pt) 2010-04-27
US20050037982A1 (en) 2005-02-17
CY1109970T1 (el) 2014-09-10
US6878691B2 (en) 2005-04-12
DE60331056D1 (de) 2010-03-11
KR100687956B1 (ko) 2007-02-28
KR20050003455A (ko) 2005-01-10
DK1506214T3 (da) 2010-05-25
ES2339647T3 (es) 2010-05-24
HK1074447A1 (en) 2005-11-11

Similar Documents

Publication Publication Date Title
ATE455786T1 (de) 6-11 bicyclische ketolidderivate
TW200634021A (en) 3,6-bicyclolides
WO2004062601A3 (en) Antibacterial agents
WO2005000863A3 (en) 6, 11-4c-bicyclic 9a-azalide derivatives
WO2005070113A3 (en) 9n-substituted 6-11 bicyclic erythromycin derivatives
UA94901C2 (ru) Антибактериальные производные пиперидина
WO2004087728A3 (en) 6,11-3c-bicyclic 9a-azalide derivatives
WO2008154642A3 (en) Antibacterial agents
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
NO20092542L (no) Antibakterielle kinolin-derivater
WO2004096823A3 (en) Novel ketolide derivatives
BR0310050A (pt) Derivados de cetolida 6-11 bicìclicas, composições farmacêuticas e processos referentes aos mesmos
NO20092539L (no) Antibakterielle kinolin-derivater
MX2010002932A (es) Macrolidos de biarilo con puente en 6, 11.
WO2006065721A3 (en) 11, 12-lactone bicyclolides
CA2483875A1 (en) 6,11 bicyclic erythromycin derivatives
TW200635600A (en) Tetracyclic bicyclolides
NO20092547L (no) Antibakterielle kinolin-derivater
WO2007044927A3 (en) 6, 11-bridged tricyclic macrolides
WO2005067564A3 (en) 6-11 bicyclic erythromycin derivatives
NO20092536L (no) Antibakterielle kinolin-derivater
NO20092540L (no) Antibakterielle kinolin-derivater
NO20092541L (no) Antibakterielle kinolin-derivater
WO2008014221A3 (en) Bridged carbamate macrolides
WO2008019240A3 (en) 3, 6-bridged tylosin derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1506214

Country of ref document: EP